Identification and validation of seven new loci showing differential DNA methylation related to serum lipid profile: an epigenome-wide approach. The REGICOR study.

Lipid traits (total, low-density and high-density lipoprotein cholesterol, and triglycerides) are risk factors for cardiovascular disease. DNA methylation is not only an inherited but also modifiable epigenetic mark that has been related to cardiovascular risk factors. Our aim was to identify loci showing differential DNA methylation related to serum lipid levels. Blood DNA methylation was assessed using the Illumina Human Methylation 450 BeadChip. A two-stage epigenome-wide association study was performed, with a discovery sample in the REGICOR study (n = 645) and validation in the Framingham Offspring Study (n = 2,542). Fourteen CpG sites located in nine genes (SREBF1, SREBF2, PHOSPHO1, SYNGAP1, ABCG1, CPT1A, MYLIP, TXNIP and SLC7A11) and 2 intergenic regions showed differential methylation in association with lipid traits. Six of these genes and 1 intergenic region were new discoveries showing differential methylation related to total cholesterol (SREBF2), HDL-cholesterol (PHOSPHO1, SYNGAP1 and an intergenic region in chromosome 2) and triglycerides (MYLIP, TXNIP and SLC7A11). These CpGs explained 0.7%, 9.5% and 18.9% of the variability of total cholesterol, HDL cholesterol and triglycerides in the Framingham Offspring Study, respectively. The expression of the genes SREBF2 and SREBF1 was inversely associated with methylation of their corresponding CpGs (P-value = 0.0042 and 0.0045, respectively) in participants of the GOLDN study (n = 98). In turn, SREBF1 expression was directly associated with HDL cholesterol (P-value = 0.0429). Genetic variants in SREBF1, PHOSPHO1, ABCG1 and CPT1A were also associated with lipid profile. Further research is warranted to functionally validate these new loci and assess the causality of new and established associations between these differentially methylated loci and lipid metabolism.

[1]  E. Feskens,et al.  Genetic variation in thioredoxin interacting protein (TXNIP) is associated with hypertriglyceridaemia and blood pressure in diabetes mellitus , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[2]  R. Elosua,et al.  Epigenome-wide association study identifies TXNIP gene associated with type 2 diabetes mellitus and sustained hyperglycemia. , 2016, Human molecular genetics.

[3]  W. Kannel,et al.  An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.

[4]  C. Martinez-Jimenez,et al.  Epigenetic crosstalk: a molecular language in human metabolic disorders. , 2015, Frontiers in bioscience.

[5]  K. Dahlman-Wright,et al.  The epigenetic signature of subcutaneous fat cells is linked to altered expression of genes implicated in lipid metabolism in obese women , 2015, Clinical Epigenetics.

[6]  Anna Decker,et al.  Considerations for normalization of DNA methylation data by Illumina 450K BeadChip assay in population studies , 2013, Epigenetics.

[7]  Andrew E. Teschendorff,et al.  Independent surrogate variable analysis to deconvolve confounding factors in large-scale microarray profiling studies , 2011, Bioinform..

[8]  J. Harrow,et al.  Systematic evaluation of spliced alignment programs for RNA-seq data , 2013, Nature Methods.

[9]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[10]  E. Kremmer,et al.  System xc− and Thioredoxin Reductase 1 Cooperatively Rescue Glutathione Deficiency* , 2010, The Journal of Biological Chemistry.

[11]  A. Simon,et al.  Characterization of polymorphic structure of SREBP-2 gene: role in atherosclerosis. , 2003, Atherosclerosis.

[12]  Jianbiao Zhou,et al.  Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer. , 2013, Mitochondrion.

[13]  Zili Zhang,et al.  A multi-filter enhanced genetic ensemble system for gene selection and sample classification of microarray data , 2010, BMC Bioinformatics.

[14]  K. Nephew,et al.  Hypermethylation of the TGF-β target, ABCA1 is associated with poor prognosis in ovarian cancer patients , 2015, Clinical Epigenetics.

[15]  D. Lindholm,et al.  Mylip makes an Idol turn into regulation of LDL receptor , 2009, Cellular and Molecular Life Sciences.

[16]  P. Peng,et al.  A Preliminary Study of the Relationship between Promoter Methylation of the ABCG1, GALNT2 and HMGCR Genes and Coronary Heart Disease , 2014, PloS one.

[17]  D. Gaudet,et al.  ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia , 2012, Epigenetics.

[18]  Jonathan A. Heiss,et al.  Type 2 diabetes and leucocyte DNA methylation: an epigenome-wide association study in over 1,500 older adults , 2015, Diabetologia.

[19]  A. Orekhov,et al.  Role of bone-type tissue-nonspecific alkaline phosphatase and PHOSPO1 in vascular calcification. , 2014, Current pharmaceutical design.

[20]  Luigi Bouchard,et al.  Epigenome-wide analysis in familial hypercholesterolemia identified new loci associated with high-density lipoprotein cholesterol concentration. , 2012, Epigenomics.

[21]  D. Gaudet,et al.  Epipolymorphisms within lipoprotein genes contribute independently to plasma lipid levels in familial hypercholesterolemia , 2014, Epigenetics.

[22]  P. D. de Jong,et al.  Positional cloning of the combined hyperlipidemia gene Hyplip1 , 2002, Nature genetics.

[23]  Yan Peng,et al.  Scorpion Venom Heat-Resistant Peptide (SVHRP) Enhances Neurogenesis and Neurite Outgrowth of Immature Neurons in Adult Mice by Up-Regulating Brain-Derived Neurotrophic Factor (BDNF) , 2014, PloS one.

[24]  L. Liang,et al.  Epigenome-Wide Association Study of Fasting Blood Lipids in the Genetics of Lipid-Lowering Drugs and Diet Network Study , 2014, Circulation.

[25]  L. Peltonen,et al.  Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1) , 2004, Nature Genetics.

[26]  D. Absher,et al.  Genome-Wide DNA Methylation Analysis of Systemic Lupus Erythematosus Reveals Persistent Hypomethylation of Interferon Genes and Compositional Changes to CD4+ T-cell Populations , 2013, PLoS genetics.

[27]  Roberto Elosua,et al.  Factores de riesgo cardiovascular. Perspectivas derivadas del Framingham Heart Study , 2008 .

[28]  M. Esteller,et al.  Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome , 2011, Epigenetics.

[29]  Lawrence B. Gardner,et al.  Stress-induced inhibition of nonsense mediated RNA decay regulates intracellular cystine transport and intracellular glutathione through regulation of the cystine/glutamate exchanger SLC7A11 , 2014, Oncogene.

[30]  Tom R. Gaunt,et al.  Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. , 2015, The lancet. Diabetes & endocrinology.

[31]  Paul Theodor Pyl,et al.  HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[32]  Denise R. Koessler,et al.  Building better interdisciplinary scientists: creating graduate level courses to address the communication gap in interdisciplinary research , 2012, BMC Bioinformatics.

[33]  N. Rajakumar,et al.  The effects of olanzapine on genome-wide DNA methylation in the hippocampus and cerebellum , 2014, Clinical Epigenetics.

[34]  M. Rewers,et al.  Relation of Combined Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B With Atherosclerosis in Adults With Type 1 Diabetes Mellitus. , 2015, The American journal of cardiology.

[35]  B. Stec,et al.  Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  Michael J. Sweredoski,et al.  Phosphorylation of Synaptic GTPase-activating Protein (synGAP) by Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) and Cyclin-dependent Kinase 5 (CDK5) Alters the Ratio of Its GAP Activity toward Ras and Rap GTPases* , 2014, The Journal of Biological Chemistry.

[37]  K. Gunderson,et al.  High density DNA methylation array with single CpG site resolution. , 2011, Genomics.

[38]  D. Hernandez,et al.  DNA Methylation of Lipid-Related Genes Affects Blood Lipid Levels , 2015, Circulation. Cardiovascular genetics.

[39]  M. Lopes-Virella,et al.  Oxidized LDL immune complexes and oxidized LDL differentially affect the expression of genes involved with inflammation and survival in human U937 monocytic cells. , 2009, Atherosclerosis.

[40]  C. O’Donnell,et al.  [Cardiovascular risk factors. Insights from Framingham Heart Study]. , 2008, Revista espanola de cardiologia.

[41]  I. Borecki,et al.  The -256T>C polymorphism in the apolipoprotein A-II gene promoter is associated with body mass index and food intake in the genetics of lipid lowering drugs and diet network study. , 2007, Clinical chemistry.

[42]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[43]  H. Blom,et al.  Thioredoxin interacting protein in Dutch families with familial combined hyperlipidemia , 2004, American journal of medical genetics. Part A.

[44]  Devin C. Koestler,et al.  DNA methylation arrays as surrogate measures of cell mixture distribution , 2012, BMC Bioinformatics.

[45]  H. González-Pacheco,et al.  Low concentrations of phospholipids and plasma HDL cholesterol subclasses in asymptomatic subjects with high coronary calcium scores. , 2015, Atherosclerosis.

[46]  Gianluca Bontempi,et al.  A comprehensive overview of Infinium HumanMethylation450 data processing , 2013, Briefings Bioinform..

[47]  E. Demerath,et al.  Epigenome-wide association study (EWAS) of BMI, BMI change and waist circumference in African American adults identifies multiple replicated loci. , 2015, Human molecular genetics.

[48]  Allan Vaag,et al.  TXNIP Regulates Peripheral Glucose Metabolism in Humans , 2007, PLoS medicine.

[49]  H. Coon,et al.  TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study. , 2004, Atherosclerosis.

[50]  Mark D. Huffman,et al.  AHA Statistical Update Heart Disease and Stroke Statistics — 2012 Update A Report From the American Heart Association WRITING GROUP MEMBERS , 2010 .

[51]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[52]  Lesley Burgess,et al.  PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial , 2015, The Lancet.

[53]  E. Eren,et al.  HDL-Associated Paraoxonase 1 as a Bridge between Postmenopausal Osteoporosis and Cardiovascular Disease , 2014, Chonnam medical journal.

[54]  An epigenetic map of age-associated autosomal loci in northern European families at high risk for the metabolic syndrome , 2015, Clinical Epigenetics.

[55]  Rafael A. Irizarry,et al.  Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays , 2014, Bioinform..

[56]  G. Lucas,et al.  Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants , 2014, The application of clinical genetics.

[57]  Y. Bossé,et al.  Acetylsalicylic acid, aging and coronary artery disease are associated with ABCA1 DNA methylation in men , 2014, Clinical Epigenetics.

[58]  G. Davey Smith,et al.  Mendelian randomization: applications and limitations in epigenetic studies. , 2015, Epigenomics.

[59]  Xiao Zhang,et al.  Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis , 2010, BMC Bioinformatics.

[60]  L. Almasy,et al.  Novel epigenetic determinants of type 2 diabetes in Mexican-American families. , 2015, Human molecular genetics.

[61]  J. Hockley,et al.  Cardiovascular risk factors. , 1988, BMJ.

[62]  E. Demerath,et al.  Epigenome-wide study identifies novel methylation loci associated with body mass index and waist circumference , 2014, Obesity.

[63]  M. Plebani,et al.  Atorvastatin Reduces Circulating Osteoprogenitor Cells and T-Cell RANKL Expression in Osteoporotic Women: Implications for the Bone-Vascular Axis. , 2016, Cardiovascular therapeutics.